Literature DB >> 1363435

[A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa].

H Takeda1, N Oogaki, N Kikuchi, H Kobayashi, T Akashi.   

Abstract

Clarithromycin (CAM) was administered long-term to patients with diffuse panbronchiolitis (DPB) to clarify the mechanism of the usefulness of the macrolides (MLs). 1. A tendency for clinical improvement was observed in 17 patients with DPB. Bacteria were eradicated in 7 of 9 patients with P. aeruginosa found in sputum. 2. A biofilm experimental model with P. aeruginosa was found to be destructed through constant contact with CAM and formed into a single cell with a smooth surface. 3. It was believed that the new lesion forming capability of P. aeruginosa that had been in contact with CAM was reduced due to a significant decrease in adherence to tissue. P. aeruginosa was principally eradicated by the host factors. These results suggested that the improvement in the prognosis of DPB with P. aeruginosa in the sputum after adding MLs was closely related to the destructive effect of the MLs on the biofilm.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1363435     DOI: 10.11150/kansenshogakuzasshi1970.66.1454

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  4 in total

Review 1.  Erythromycin and diffuse panbronchiolitis.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

2.  Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection.

Authors:  T Fujii; J Kadota; K Kawakami; K Iida; R Shirai; M Kaseda; S Kawamoto; S Kohno
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

3.  Clinical profiles of Chinese patients with diffuse panbronchiolitis.

Authors:  K W Tsang; C G Ooi; M S Ip; W K Lam; H Ngan; E Y Chan; B Hawkins; C S Ho; R Amitani; E Tanaka; H Itoh
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

4.  Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis.

Authors:  H Yasuda; Y Ajiki; T Koga; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.